Article Text

PDF
Original article
High prevalence of adenomatous colorectal polyps in young cancer survivors treated with abdominal radiation therapy: results of a prospective trial
  1. Patricia E Daly1,
  2. Sara Samiee2,
  3. Maria Cino3,
  4. Robert Gryfe4,
  5. Aaron Pollett5,
  6. Andrea Ng6,
  7. Louis S Constine7,
  8. David C Hodgson1,8
  1. 1 Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada
  2. 2 Hematology Oncology and BMT Research Centre, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
  3. 3 Department of Gastroenterology, Toronto Western Hospital, Toronto, Ontario, Canada
  4. 4 Department of Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada
  5. 5 Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
  6. 6 Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA
  7. 7 Department of Radiation Oncology, University of Rochester Medical Center, Rochester, New York, USA
  8. 8 Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada
  1. Correspondence to Dr David C Hodgson, Radiation Medicine Program, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, Ontario, Canada M5G 2M9; David.Hodgson{at}rmp.uhn.on.ca

Abstract

Objective Cancer survivors treated with abdominal/pelvic radiation therapy (ART) have increased the risks of colorectal cancer (CRC), although evidence supporting early CRC screening for these patients is lacking. We sought to determine whether there is an elevated prevalence of adenomatous colorectal polyps in young survivors prior to the age when screening would be routinely recommended.

Design We conducted a prospective study of early colonoscopic screening in cancer survivors aged 35–49 who had received ART ≥10 years previously. The planned sample size was based on prior studies reporting a prevalence of adenomatous polyps of approximately 20% among the average-risk population ≥50 years of age, in contrast to ≤10% among those average-risk people aged 40–50 years, for whom screening is not routinely recommended.

Results Colonoscopy was performed in 54 survivors, at a median age of 45 years (range 36–49) and after median interval from radiation treatment of 19 years (10.6–43.5). Forty-nine polyps were detected in 24 patients, with 15 patients (27.8%; 95% CI 17.6% to 40.9%) having potentially precancerous polyps. Fifty-three per cent of polyps were within or at the edge of the prior ART fields.

Conclusions Young survivors treated with ART have a polyp prevalence comparable with the average-risk population aged ≥50 years and substantially higher than previously reported for the average-risk population aged 40–50 years. These findings lend support to the early initiation of screening in these survivors.

Clinical trial registration number NCT00982059; results.

  • COLORECTAL CANCER SCREENING
  • COLONOSCOPY
  • COLORECTAL CANCER

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.